Abhijit Date to Administration, Oral
This is a "connection" page, showing publications Abhijit Date has written about Administration, Oral.
Connection Strength
0.485
-
Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release. 2016 10 28; 240:504-526.
Score: 0.132
-
Date AA, Vador N, Jagtap A, Nagarsenker MS. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery. Nanotechnology. 2011 Jul 08; 22(27):275102.
Score: 0.093
-
Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, Aswal V, Steiniger F, Thamm J, Fahr A. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol Pharm. 2011 Jun 06; 8(3):716-26.
Score: 0.093
-
Date AA, Nagarsenker MS. Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. J Pharm Pharmacol. 2007 Nov; 59(11):1583-4.
Score: 0.073
-
Patel P, Pol A, Kalaria D, Date AA, Kalia Y, Patravale V. Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson's therapy. Eur J Pharm Biopharm. 2021 Aug; 165:66-74.
Score: 0.046
-
Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. Sulfobutyl ether(7) ?-cyclodextrin (SBE(7) ?-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS PharmSciTech. 2011 Dec; 12(4):1163-75.
Score: 0.024
-
Khachane P, Date AA, Nagarsenker MS. Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration. J Biomed Nanotechnol. 2011 Aug; 7(4):590-7.
Score: 0.024